The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

1. Forero-Castro, M.
2. Robledo, C.
3. Lumbreras, E.
4. Benito, R.
5. Hernández-Sánchez, J.M.
6. Hernández-Sánchez, M.
7. García, J.L.
8. Corchete-Sánchez, L.A.
9. Tormo, M.
10. Barba, P.
11. Menárguez, J.
12. Ribera, J.
13. Grande, C.
14. Escoda, L.
15. Olivier, C.
16. Carrillo, E.
17. García de Coca, A.
18. Ribera, J.-M.
19. Hernández-Rivas, J.M.